Kailera Therapeutics announced its third quarter 2026 financial results and progress on its obesity drug pipeline. The company is advancing multiple GLP-1-based treatments, including ribupatide oral and injection, safiglipron, and KAI-4729, with key clinical trial data expected between mid-2027 and mid-2028. Kailera has over $1 billion in cash to support operations through mid-2028. The company plans to start a global Phase 3 trial for ribupatide oral in early 2027 and anticipates important data readouts from ongoing trials, aiming to offer improved obesity treatments.
Kailera Therapeutics' Q3 2026 financial results and drug pipeline updates are presented here alongside Pluang's health sector market snapshot. As of Nov 05, 2026 04:11 WIB, out of 150 priced health-sector US stocks on Pluang, 108 advanced and 42 declined. Notable movers include HCA Health Inc at USD 510.87 with a 10.37% gain and a 65% buy order activity, Novavax Inc at USD 10.64 up 9.92% with 84% buy orders, and Envista Holdings Corporation at USD 27.17 rising 9.69%, with typical hold times ranging from 11 to 77 days.
At the 2026 Chery International User Summit, Chery Auto showcased its new physical AI technology built on decades of automotive safety data and engineering. Their CheryMind AI model and CHERY All-World Engine support autonomous robots, robotaxis, and...
NOVAGOLD shareholders approved a transaction for New NOVAGOLD to acquire the remaining 40% interest in the Donlin Gold project from Paulson Advisers, increasing NOVAGOLD's ownership from 60% to 100%. This consolidation makes New NOVAGOLD the ultimate...
Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...
3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000...
The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...
